CSL.AX acquires VIFN.SW for CHF167($179.25)/sh cash—a 51% premium to Vifor’s closing price on 12/10/21: https://finance.yahoo.com/news/australia-csl-buy-drugmaker-vifor-064050454.html The nominal deal value is $11.7B.